Rolaids Line Expands Into Gas Relief With Multi-Symptom Extension
This article was originally published in The Tan Sheet
Executive Summary
Pfizer is positioning new Rolaids Multi-Symptom line extension as handling gas as well as heartburn in comparison to GlaxoSmithKline's Tums in spots that broke November 17
You may also be interested in...
Tums takes on competition
Pepcid AC "takes, like, 40 minutes to start working," according to female diner patron in Tums spot that launched Sept. 30 and focuses on Tums' quick action. Diner cook states "Tums starts neutralizing acid fast," tells male patron using Prilosec OTC, "Read the label, that can take one to four days to kick in." Referring to delayed-release PPI, cook notes "it should say delayed relief." Pepcid AC-marketer Johnson & Johnson/Merck has clashed with Tums marketer GlaxoSmithKline over ad claims through National Advertising Division (1"The Tan Sheet" Aug. 6, 2001, p. 4)...
J&J/Merck Bolsters Heartburn Lineup With Maximum Strength Pepcid AC
New heartburn prevention/relief product Maximum Strength Pepcid AC will hit shelves Oct. 17, following FDA approval of the new dosage Sept. 24, according to Johnson & Johnson/Merck
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC